pegilodecakin

Pegilodecakin for metastatic kidney cancer

By Robert|2021-07-07T13:01:07+00:0025 Jun 2021|Drug treatments|

Combinations of immunotherapy and vascular endothelial growth factor (VEGF) inhibitors [...]

Comments Off

Pegilodecakin alone or in combination for heavily pre-treated advanced kidney cancer patients

By Robert|2021-07-07T11:02:43+00:009 Apr 2021|Drug treatments|

This study looked at the use of pegilodecakin alone or [...]

Comments Off

Promising early studies with pegilodecakin plus immunotherapy in pretreated kidney cancer

By Sharon Kell|2019-10-07T09:11:56+00:007 Oct 2019|Drug treatments|

A recent phase 1b clinical trial investigated the use of [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org